New recall affects certain LEADER brand eye drops; FDA says it found unsanitary conditions in facility where they are manufactured
THURSDAY, Nov. 2, 2023 (HealthDay News) — Cardinal Health is voluntarily recalling certain LEADER brand eye drops because they may cause eye infections.
The U.S. Food and Drug Administration informed the Dublin, Ohio, company that agency investigators found unsanitary conditions in its manufacturing facility. Tests of critical drug production areas of the facility were positive for bacteria. The drops were supplied by Velocity Pharma.
Cardinal Health has received reports of three adverse events related to these products and have shared this information with its supplier, the recall notice said.
These eye drops are sold over the counter for temporary relief of burning and irritation due to dryness, to protect against further irritation, and to relieve redness. They were sent to wholesalers and retailers starting in December 2021.
While the company is notifying its direct accounts via mail and arranging for return of the products, wholesalers, distributors, and retailers should stop selling the eye drops.
Consumers should also stop using them. They may return any of the recalled products to the place they bought them.
Ambient Temperature Linked to Intraocular Pressure in Glaucoma 
Dexamethasone Eye Drops Can Reduce Progression to ROP Requiring Treatment 
Atropine Eye Drops Reduce Myopia Progression in Children 
Inclined Sleeper-Associated Sudden Unexpected Infant Deaths Continued After Recall 
Nearly 2 in 3 Poison Exposures in Young Children May Not Need the ED 
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Non-Children"s Hospitals More Commonly Use Imaging Exposing Children to Ionizing Radiation 
Remotely Located Technician Noninferior for Car Seat Installation 
